PRALSETINIB

Clinical trials for PRALSETINIB explained in plain language.

Never miss a new study

Get alerted when new PRALSETINIB trials appear

Sign up with your email to follow new studies for PRALSETINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a white blood cell booster help lung cancer patients on targeted therapy?

Disease control Not yet recruiting

This study looks at whether a drug called Leucogen can prevent low white blood cell counts (leukopenia) in people with RET fusion-positive non-small cell lung cancer who are being treated with pralsetinib. The study will enroll 25 people who have not had prior treatment. Research…

Matched conditions: PRALSETINIB

Phase: NA • Sponsor: Fudan University • Aim: Disease control

Last updated May 13, 2026 15:58 UTC

PRALSETINIB

Get alerted when new PRALSETINIB trials appear

Can a white blood cell booster help lung cancer patients on targeted therapy?